By Vigilare Biopharma October 15, 2025Clinical Trails
Introduction
The clinical research landscape is evolving rapidly. Traditional site-based trials, while foundational, often face limitations in patient recruitment, retention, and geographic reach. Decentralised Clinical Trials (DCTs) are emerging as a transformative model — bringing research directly to patients through digital innovation.
What Are Decentralised Clinical Trials?
DCTs utilise remote monitoring, telemedicine, mobile health apps, and direct-to-patient drug delivery. This reduces the need for physical site visits and enhances trial accessibility, especially for patients in remote or underserved regions.
Key Benefits
Improved Patient Access Faster Recruitment Timelines Real-Time Data Collection Cost Efficiency Greater Demographic Diversity
Vigilare’s Commitment
At Vigilare Biopharma, we are integrating decentralised models into our clinical operations to uphold our core values:
Ethical Research Clinical Excellence Patient Safety
Our teams are trained in remote trial management, and we collaborate with technology partners to ensure secure, compliant data handling.
Looking Ahead
As global regulators adapt to decentralised models, DCTs are poised to become a standard in drug development. Vigilare is proud to lead this evolution, ensuring innovation never compromises integrity.
